Editorial - (2021) Volume 12, Issue 1
LONGDOM Journal of Diabetes & Metabolism has been started in the year 2010 and it released its first volume in the same year. Till now, the journal has released 11 volumes by the end of 2020 and is successfully running its 12th Volume.
The Journal of Diabetes & Metabolism is an open access publication that features scientific works of considerable significance and impact in all fields of Diabetes research such as: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Monogenic Diabetes, and cystic fibrosis-related diabetes, Latent autoimmune diabetes of adults (LADA), Diabetic Neuropathy, Diabetic Retinopathy, Diabetic Nephropathy, Diabetic hypoglycemia, and Obesity. The scope of the journal is not just restricted to Diabetes alone; works related to endocrinology, genetics, physiology, or cardio-vascular diseases which are loosely associated with Diabetes are equally welcome. It is a boon for researchers and students who wish to be kept abreast of the latest advancements in the field of Diabetes, it would help them build on the current know-how. Business people, policy makers, journalists, and practitioners can also benefit from the works published in the journal.
Classification of the Journal
1. Type 1 Diabetes
2. Type 2 Diabetes
3. Advances of Diabetes Cure
4. Childhood Diabetes
5. Hyperglycemia and Hypoglycemia
6. Diabetes and Alcohol
7. Diabetes and Weight Loss
8. Diabetes Cholestrol
9. Diabetes Lipid Metabolism
10. Diabetes Statistics
11. Latest Research on Diabetes
12. Obesity and Diabetes
13. Pathophysiology of Diabetes
The classification extends to the above and its related topics too.
During the year 2020, the Journal has released nearly 40 articles. During May, Longdom Group has acquired this journal from Omics group and from then on, all rights has been taken by the Longdom Group only.
Some of the articles released in 2019 and 2020 are as follows:
1. A Comparative Study of Waist Hip Ratio and Body Mass Index (BMI) in Diabetic and Non Diabetic Individuals of Chitwan, Nepal.
2. A Prospective, Multicentre, Single Arm Clinical Study to Evaluate the Effect of Saroglitazar on Non High-Density Lipoprotein Cholesterol in Patients with Diabetic Dyslipidemia Inadequately Controlled with Diet, Exercise, and Statin- The GLIDDER Study.
3. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part III. Type I or II Diabetogenic Effects of Streptozocin.
4. Assessment of 8-Hydroxy-2- Deoxyguanosine (8-OHdG) as a Diagnostic Marker for Diabetic Nephropathy in Type 1 Egyptian Diabetic Patients.
5. The Efficacy and Safety of Teneligliptin and Metformin versus Glimepiride and Metformin in Patients of Type-2 Diabetes Mellitus Uncontrolled with Monotherapy.
Citation: Karunasree P (2021) Editorial-Journal of Diabetes & Metabolism. J Diabetes Metab 12:e101.
Received: 25-Jan-2021 Published: 28-Jan-2021, DOI: 10.35248/2155-6156.21.12.e101
Copyright: © 2021 Karunasree P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
